Daktari Diagnostics, Inc is a diagnostics company with a microfluidics and electrochemical sensing device for low-cost, accurate, easy to deploy point of care CD4 cell assay.
Sage Science designs and develops instrumentation for research and diagnostic applications. Its Pippin Prep technology frees the research community from the cost and labor of working with DNA by analyzing, preparing and concentrating samples automatically in much less time, cost and labor than traditional methods.
Life Image is a web based Radiology image sharing platform.
Momelan offers a paradigm shift in skin grafting. Our elegant device-based technology is lower cost, more effective, and more widely applicable than any existing technology. Expanding from vitiligo to other applications, we serve markets left behind.
Thermalin Diabetes, LLC is a Cleveland-based biotechnology company developing a portfolio of next generation insulin analogs for both the $8B rapid-acting and the $4B long acting insulin markets.
PolyTouch Medical is a pioneer of mesh deployment and placement devices for laparoscopic hernia repair.
Lantos Technologies is working to commercialize a 3D digital scanner capable of measuring ear canal shape and tissue compliance.
Bliss Healthcare (BH) brings comprehensive premium healthcare to patients at home so families stay connected yet care for aging parents, loved ones.
Annovation is developing safer IV anesthetics drug for induction & short term maintenance of general anesthesia.
Avaxia Biologics is developing oral antibody products for diseases of the GI tract, including mucositis, inflammatory bowel disease and diabetes and obesity.
Diffinity Genomics is developing laboratory tools to simplify the preparation of genomic samples.
Sialix is developing a breakthrough cancer therapeutic platform which will create multiple therapeutics for ovarian, breast, colon and other solid tumors, and an anti-inflammatory nutritional supplement to reduce the risks of diseases (cancer and cardiovascular disease) associated with dietary red meat. Sialix's scientific foundation was developed at UCSD at the Varki lab, a world-leader in glycobiology.
ZetrOZ Inc. is an innovative medical device company established in 2009 which designs, manufactures, and distributes wearable ultrasound therapeutic solutions that change the way people care for their acute and chronic injuries. The current ZetrOZ ultrasound therapy system is drug free and prescription strength to maximize recovery.
JB Therapeutics is a clinical stage company developing breakthrough drugs for the treatment of orphan inflammatory diseases. It’s lead compound, JBT-101, is a novel, safe, oral synthetic endocannabinoids with potent anti-inflammatory activity. JBT-101 is being clinically developed for the treatment for scleroderma, a debilitating disease with no known cure and inadequate therapies.
AesRx is a biopharmaceutical company dedicated to the development of two novel drugs, each of which targets an orphan disease. AesRx’s lead program, Aes-103, is a potential breakthrough in the treatment of sickle cell disease (SCD). AesRx has commenced a Phase 2 clinical trial of Aes-103 as part of an ongoing collaboration with the NIH. AesRx’s second development program, Aes-210, is targeted to treat certain inflammatory diseases of the lower intestine, including ulcerative colitis, distal ulcerative colitis, pouchitis and radiation induced proctitis.
InfoBionic is a medical device company creating portable heart arrhythmia detection devices.